Sep 2026· Gan to kagaku ryoho. Cancer & chemotherapy· Vol 53 9, pp.
560-565
· 0 citations
Medicine
TL;DR
The findings suggest that JMJD6 functions as a dual regulator of tumor aggressiveness and immune escape, highlighting its utility as a prognostic factor and a promising therapeutic target in GC.
Findings associate JMJD2D with aggressive clinical and experimental phenotypes in lung cancer and support further investigation of its molecular role and therapeutic relevance.
Qiu-Xia Lu, Yi-Cong Tang, Si-Da Li et al.· Cellular Signalling· 0 citations
Hepatocellular carcinoma (HCC) is driven by cancer stemness and an immunosuppressive tumor microenvironment, which collectively contribute to therapeutic resistance. While the RNA-binding protein HNRNPC has been implicated in tumor progression, it has primarily been characterized as a downstream effector, and its auton...
D. Ye, Xue-Yin Pan, Jia-Qing Chen et al.· Cancer Letters· 0 citations
Lung Adenocarcinoma (LUAD) represents the most prevalent subtype of lung cancer and additionally possesses the highest potential for lethality. EXO1 is overexpressed in multiple cancers and linked to poor prognosis, but its role in LUAD immune regulation remains unclear. Immunosuppression can be stimulated by HIF-1α, w...
The role of non-histone lysine methylation in tumorigenesis has attracted increasing attention, and the dysregulated “writers”, “erasers” and “readers” of it are promising therapeutic targets. In this study, we demonstrated that lysine-specific demethylase 4B (KDM4B) was significantly upregulated in renal cell carc...
Zi-Ran Dai, Ming-Xiao Zhang, Hao Zhou et al.· Cell Death & Disease· 0 citations
BACKGROUND
c-MET overexpression is common in non-small cell lung cancer (NSCLC) and associated with poor prognosis, however, its role in immune evasion and immunotherapy resistance remains unclear.
METHODS
We analyzed c-MET expression in public "The Cancer Genome Atlas NSCLC" cohort (n = 1043) and an institutional co...
Li-Jin Chen, Xi-Hu Yao, Chun-Yan Su et al.· International Immunopharmaco...· 1 citation
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality, and PD-L1-mediated immune evasion is a major mechanism of tumor immune suppression and an important target of immune checkpoint blockade. Here, we identified RNF166 as an E3 ubiquitin ligase that promotes immune evasion in HCC. RNF166 expres...
B. Ren, Yi-Chen Yang, Kai-Wen Sheng et al.· Apoptosis· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.